0000899243-20-032918.txt : 20201207 0000899243-20-032918.hdr.sgml : 20201207 20201207200048 ACCESSION NUMBER: 0000899243-20-032918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201204 FILED AS OF DATE: 20201207 DATE AS OF CHANGE: 20201207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McIntyre Gail Frances CENTRAL INDEX KEY: 0001492646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36361 FILM NUMBER: 201374130 MAIL ADDRESS: STREET 1: C/O FURIEX PHARMACEUTICALS, INC. STREET 2: 3900 PARAMOUNT PARKWAY, SUITE 150 CITY: MORRISVILLE STATE: NC ZIP: 27560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aravive, Inc. CENTRAL INDEX KEY: 0001513818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264106690 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 3730 KIRBY DRIVE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: 936-355-1910 MAIL ADDRESS: STREET 1: RIVER OAKS TOWER STREET 2: 3730 KIRBY DRIVE, SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: Versartis, Inc. DATE OF NAME CHANGE: 20110223 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-04 0 0001513818 Aravive, Inc. ARAV 0001492646 McIntyre Gail Frances C/O ARAVIVE, INC., RIVER OAKS TOWER, 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 1 1 0 0 CEO and President Common Stock 2020-12-04 4 P 0 8000 5.77 A 10137 D Includes an aggregate of 2,137 shares acquired by the reporting person under the Aravive, Inc. 2014 Employee Stock Purchase Plan, of which 416 shares were acquired on each of May 15, 2019, November 15, 2019 and May 15, 2020, respectively and 889 shares were acquired on November 13, 2020. /s/ Abel Svitavsky, Attorney-in-fact 2020-12-07